查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493247

DNase、連接酶、RNA聚合酵素市場規模、佔有率、趨勢分析報告：按應用、按地區、細分市場預測，2024-2030 年

DNases, Ligases, And RNA Polymerases Market Size, Share & Trends Analysis Report By Application (DNases-Biopharmaceutical Processing, Ligases- ligonucleotide Synthesis), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

DNase、連接酶、RNA聚合酵素市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球 DNase、連接酶和 RNA聚合酵素市場規模預計將達到 16.2 億美元。

預計2024年至2030年複合年成長率為10.63%。研發費用的增加是推動市場成長的主要因素之一。此外，生物製藥產量的增加以及對 DNA 相關創新的關注預計也將對預測期內全球 DNase 市場的成長產生積極影響。

例如，2020 年 6 月，Alphazyme 和 Codexis 建立了策略合作夥伴關係，為診斷和研究用途提供新型酵素。近年來，由於 DNA 酶在製藥應用中擴大採用等因素，DNA 酶持續獲得顯著的市場佔有率，這對於治療各種慢性和消化器官系統疾病至關重要。此外，生物技術和製藥領域的發展，例如基因工程和蛋白質工程的引入，有助於擴大酶的應用，預計將在預測期內提供利潤豐厚的成長機會。

據估計，增加研發投資以開發連接酶作為癌症治療的目標將在預測期內推動該行業的發展。此外，主要製造商的策略活動可能會在預測期內提供利潤豐厚的成長機會。促進該領域成長的其他因素包括醫療保健的進步、醫療和生命科學領域對現代化的需求增加、政府對基因組技術開發的投資增加以及私營和公共研究公司對寡核苷酸合成的需求迅速增加。是推高的一個因素

COVID-19疫情為RNA聚合酵素的應用提供了有利的機會。目前，有超過 150 種疫苗和療法在生產過程中使用 mRNA 或基於 mRNA 分子，並正在評估是否適用於多種治療方法。許多 mRNA 疫苗已被世界各國核准緊急使用。

例如，Moderna的mRNA-1273和BioNTech/輝瑞的BNT-162疫苗已被核准在世界多個地區使用。此外，還有 mRNA 疫苗開發進行巨額資本投資的例子。例如，2021年6月，賽諾菲宣布對mRNA疫苗研發中心每年投資約452.12美元。

DNase、連接酶、RNA聚合酵素市場報告亮點：

  • 從 DNAase 應用來看，由於基於 DNA 的研究不斷增加、研究經費不斷增加以及 DNase 的可靠效用，其他應用領域將在 2023 年佔據市場主導地位。
  • 以連接酶應用來看，2023年其他應用領域佔最大。某些因素，例如基因治療中連接酶的使用增加和 DNA定序的成長，預計將在預測期內的細分市場成長中發揮重要作用。
  • 由於對基於 mRNA 的 COVID-19 疫苗和研究活動的需求不斷增加，透過應用 RNA聚合酵素，mRNA 生產將在 2023 年佔據市場主導地位。例如，Moderna 計劃透過三個新開發項目擴大其 mRNA 疫苗管道。這些項目將針對水痘帶狀皰疹病毒（VSV）、單純皰疹病毒（HSV）和新型查核點癌症疫苗。
  • 由於基因治療需求的增加、遺傳疾病和癌症數量的增加、研究機構的存在、新基因治療研究的研究支出增加以及基於 DNA 的疫苗生產需求壟斷了全球市場。
  • 由於遺傳病患病率上升、基因治療需求增加以及人口密度高，預計亞太地區未來將顯著成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 DNase、連接酶、RNA聚合酵素市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • DNase、連接酶、RNA聚合酵素市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 DNase、連接酶、RNA聚合酵素市場：DNase應用預估及趨勢分析

  • 細分儀表板
  • 全球DNase、連接酶、RNA聚合酵素市場DNase應用波動分析
  • 全球 DNase、連接酶、RNA聚合酵素市場規模及趨勢分析：依 DNase 應用分類，2018-2030 年
  • 生物製藥加工
  • 其他用途

第5章 DNase、連接酶、RNA聚合酵素市場：連接酶使用量估計與趨勢分析

  • 細分儀表板
  • 全球DNase、連接酶、RNA聚合酵素市場連接酶應用變化分析
  • 全球DNA酶、連接酶、RNA聚合酵素市場規模及趨勢分析：依連接酶應用，2018-2030年
  • 寡核苷酸合成
  • 其他用途

第6章 DNase、連接酶、RNA聚合酵素市場：RNA聚合酵素使用量估算與趨勢分析

  • 細分儀表板
  • 全球DNase、連接酶、RNA聚合酵素市場RNA聚合酵素應用變化分析
  • 全球 DNase、連接酶、RNA聚合酵素市場規模及趨勢分析：按 RNA聚合酵素應用分類，2018-2030 年
  • mRNA生產
  • 其他用途

第 7 章 DNase、連接酶、RNA聚合酵素市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Promega Corporation
    • New England Biolabs
    • RayBiotech, Inc.
    • BioVision, Inc.
    • ABclonal, Inc.
    • QIAGEN NV
    • Takara Bio, Inc.
    • Abnova Corporation.
    • Calzyme
    • ArcticZymes Technologies
    • Worthington Biochemical Corporation
    • MBL International
    • MyBioSource
    • BPS Bioscience Inc.
    • Sino Biological
    • Novus Biologicals
Product Code: GVR-4-68039-982-9

DNases, Ligases, And RNA Polymerases Market Growth & Trends:

The global DNases, ligases, and RNA polymerases market size is expected to reach USD 1.62 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.63% from 2024 to 2030. Increasing research and development expenditure is one of the key factors fueling market growth. Furthermore, rising biopharmaceutical production along with a focus on DNA-related innovations is expected to positively impact the global DNases market growth over the forecast period.

For instance, in June 2020, Alphazyme and Codexis entered into a strategic partnership to provide novel enzymes for diagnostics and research. DNases have continued to garner a significant market share in recent years owing to factors such as an increase in the adoption of DNA enzymes related to pharmaceuticals, which are essential for the treatment of various chronic disorders and digestive diseases. In addition, developments in the biotechnology and pharmaceutical fields, such as the introduction of genetic and protein engineering, have helped in expanding applications of enzymes, which is expected to offer lucrative growth opportunities in the forecast period.

An increase in R&D investments to develop ligases as the target for therapeutic applications in cancer is estimated to drive the segment in the forecast period. In addition, strategic activities by major manufacturers will offer lucrative growth opportunities in the projected period. Other factors augmenting segment growth include advancements in healthcare, increasing demand for modernization in the field of medical academics and life sciences, growing investments by governments to develop genomic technologies, and a surge in the demand for oligonucleotide synthesis by private and public research firms.

The COVID-19 pandemic situation has offered lucrative opportunities for RNA polymerase applications. Currently, there are over 150 vaccines and therapeutics that either use mRNA in their production processes or are based on mRNA molecules, which are being assessed for the treatment of a wide range of indications. Many mRNA vaccines are approved for emergency use in many countries across the globe.

For instance, Moderna's mRNA-1273 and BioNTech/ Pfizer BNT-162 vaccines have been approved for use across various regions globally. Moreover, there are instances of huge capital investments for the development of mRNA vaccines. For instance, in June 2021, Sanofi declared an investment of around USD 452.12 annually for its mRNA vaccines development center.

DNases, Ligases, And RNA Polymerases Market Report Highlights:

  • By DNAse application, the other applications segment dominated the market in 2023 due to a rise in DNA-based research, an increase in research funding, and reliable utility of DNase in applications
  • By ligase application, the other applications segment held the maximum share in 2023. Certain factors such as the rising use of ligases in gene therapies and growth in DNA sequencing are expected to play a major role in the segment growth during the forecast period
  • By RNA polymerases application, mRNA production dominated the market in 2023 due to increasing demand for mRNA-based vaccines for COVID-19 and research activities. For instance, Moderna is set to expand its mRNA vaccine pipeline with three new development programs. The programs will target the varicella-zoster virus (VSV), herpes simplex virus (HSV), and a novel checkpoint cancer vaccine
  • North America dominated the global market in 2023 owing to increasing demand for gene therapy, rise in the number of genetic disorders and cancer, the presence of research institutes, rising research funding for research on novel gene therapy, and rise in the demand for DNA-based vaccine production for COVID-19
  • Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of genetic disorders, rising demand for gene therapy, and high population density

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. DNases Application
    • 1.2.2. Ligases Application
    • 1.2.3. RNA Polymerases Application
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. DNases, Ligases, And RNA Polymerases Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing academic and industrial interest in mRNA technology
      • 3.2.1.2. Advancements in biotechnology and molecular biology
      • 3.2.1.3. Increasing demand for gene therapy
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory challenges related to DNases, ligases, And RNA polymerases
  • 3.3. DNases, Ligases, And RNA Polymerases Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNases, Ligases, And RNA Polymerases Market: DNases Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global DNases, Ligases, And RNA Polymerases Market DNases Application Movement Analysis
  • 4.3. Global DNases, Ligases, And RNA Polymerases Market Size & Trend Analysis, by DNases Application, 2018 to 2030 (USD Million)
  • 4.4. Biopharmaceutical Processing
    • 4.4.1. Biopharmaceutical processing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Other Applications
    • 4.5.1. Other applications market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. DNases, Ligases, And RNA Polymerases Market: Ligases Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global DNases, Ligases, And RNA Polymerases Market Ligases Application Movement Analysis
  • 5.3. Global DNases, Ligases, And RNA Polymerases Market Size & Trend Analysis, by Ligases Application, 2018 to 2030 (USD Million)
  • 5.4. Oligonucleotide Sysnthesis
    • 5.4.1. Oligonucleotide synthesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Other Applications
    • 5.5.1. Other applications methylation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. DNases, Ligases, And RNA Polymerases Market: RNA Polymerases Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global DNases, Ligases, And RNA Polymerases Market RNA Polymerases Application Movement Analysis
  • 6.3. Global DNases, Ligases, And RNA Polymerases Market Size & Trend Analysis, by RNA Polymerases Application, 2018 to 2030 (USD Million)
  • 6.4. mRNA Production
    • 6.4.1. mRNA production market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Other Applications
    • 6.5.1. Other applications market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. DNases, Ligases, And RNA Polymerases Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Mexico
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Agilent Technologies, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Promega Corporation
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. New England Biolabs
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. RayBiotech, Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. BioVision, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. ABclonal, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. QIAGEN N.V.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Takara Bio, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Abnova Corporation.
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Calzyme
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. ArcticZymes Technologies
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Worthington Biochemical Corporation
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. MBL International
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. MyBioSource
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. BPS Bioscience Inc.
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Sino Biological
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. Novus Biologicals
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Key funding for mRNA R&D in 2020 - 2022
  • Table 3 Clinical development of mRNA vaccine candidates against COVID-19
  • Table 4 Global DNases, ligases, and RNA polymerases market, by region, 2018 - 2030 (USD Million)
  • Table 5 Global DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 6 Global DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 7 Global DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 8 Global DNases, ligases, and RNA polymerases market, 2018 - 2030 (USD Million)
  • Table 9 North America DNases, ligases, and RNA polymerases market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 11 North America DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 12 North America DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 16 Canada DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 17 Canada DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 18 Canada DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 19 Europe DNases, ligases, and RNA polymerases market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 21 Europe DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 22 Europe DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 23 Germany DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 24 Germany DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 25 Germany DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 26 UK DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 27 UK DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 28 UK DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 29 France DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 30 France DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 31 France DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 32 Italy DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 33 Italy DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 34 Italy DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 35 Spain DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 36 Spain DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 37 Spain DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 38 Denmark DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 39 Denmark DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 40 Denmark DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 41 Sweden DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 42 Sweden DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 43 Sweden DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 44 Norway DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 45 Norway DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 46 Norway DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific DNases, ligases, and RNA polymerases market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 51 China DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 52 China DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 53 China DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 54 Japan DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 55 Japan DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 56 Japan DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 57 India DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 58 India DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 59 India DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 60 South Korea DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 61 South Korea DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 62 South Korea DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 63 Australia DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 64 Australia DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 65 Australia DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 66 Thailand DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 67 Thailand DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 68 Thailand DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 69 Latin America DNases, ligases, and RNA polymerases market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 71 Latin America DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 72 Latin America DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 73 Brazil DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 74 Brazil DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 75 Brazil DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 76 Mexico DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 77 Mexico DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 78 Mexico DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 79 Argentina DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 80 Argentina DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 81 Argentina DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 82 MEA DNases, ligases, and RNA polymerases market, by country, 2018 - 2030 (USD Million)
  • Table 83 MEA DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 84 MEA DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 85 MEA DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 86 South Africa DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 87 South Africa DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 88 South Africa DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 92 UAE DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 93 UAE DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 94 UAE DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait DNases, ligases, and RNA polymerases market, by DNases application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait DNases, ligases, and RNA polymerases market, by ligases application, 2018 - 2030 (USD Million)
  • Table 97 Kuwait DNases, ligases, and RNA polymerases market, by RNA polymerases application, 2018 - 2030 (USD Million)
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing expansions
  • Table 101 Key companies undertaking new launch
  • Table 102 Key companies undertaking new launch

List of Figures

  • Fig. 1 DNases, ligases, and RNA polymerases market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validation & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market snapshot
  • Fig. 13 Segment snapshot - 1
  • Fig. 14 Segment snapshot - 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Biotechnology market value, 2023 (USD billion)
  • Fig. 17 Market trends & outlook
  • Fig. 18 Gene therapies in clinical trials in 2022 globally
  • Fig. 19 PESTEL analysis
  • Fig. 20 Porter's five forces analysis
  • Fig. 21 DNases market: Application outlook & key takeaways
  • Fig. 22 DNases market: Application movement analysis
  • Fig. 23 Global biopharmaceutical processing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ligases market: Application outlook & key takeaways
  • Fig. 26 Ligases market: Application movement analysis
  • Fig. 27 Global oligonucleotide synthesis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 RNA polymerases market: Application outlook & key takeaways
  • Fig. 30 RNA polymerases market: Application movement analysis
  • Fig. 31 Global mRNA production market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global other applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace outlook, 2023 & 2030, (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 U.S. DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Canada DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Germany DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 UK DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 France DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Italy DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Spain DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Denmark DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Norway DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Sweden DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 China DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 India DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Thailand DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 South Korea DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Singapore DNases, Ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Brazil DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Mexico DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Argentina DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 MEA DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Africa DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Saudi Arabia DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 UAE DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Kuwait DNases, ligases, and RNA polymerases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Market participant categorization
  • Fig. 89 Global DNases, ligases, and RNA polymerases market heat map analysis, 2023
  • Fig. 90 Strategic framework